Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
understanding of immune responses in the eye, develop and validate new biomarkers, and directly improve patient care. Working with Professor Laura Downie, you'll contribute to the strategic direction
-
studies of depression risk in non-European ancestry populations. We’re also leading cutting-edge new studies examining baby teeth as novel biomarkers for mental health risk. Collaborate and Innovate with a
-
computational immunology. Human immuno-oncology research in an academic or industry setting analyzing clinical trial biomarkers is a plus. Hands-on experience with image analysis and processing, particularly in
-
prodromal cohorts and link them to clinical readouts and α-synuclein reactivity. Use cutting-edge single-cell and immune-profiling approaches, linked to clinical phenotyping, to discover early biomarkers and
-
biochemistry, bioinformatics, single cell genomics, epigenetics, pharmacology and pathology. The Nelson laboratory website provides additional information: https://research.fhcrc.org/peternelson/en.html
-
translational research studies. Provides support of biomarker discovery and validation projects for translational research studies as well as animal model research studies. Prepares billing for completed work
-
. Results will be compared with new biomarker-based paleo-hydroclimate proxy records being generated in the Climate and Paleoclimate Lab as well as other records from the region. The postdoc will also
-
engaged in a wide range of collaborations from basic science, high-dimensional multiomics data analyses, translational research, epidemiology studies, biomarker selection, to clinical trials at HCI. We
-
the model systems developed. 3. Have in-depth knowledge of developing human patient derived organoid, co-culture and explant systems, for exploitation in drug and biomarker development. 4. Establish
-
of the grant: Bruno José Fernandes Oliveira Manadas IV - Work Plan / Goals to be achieved: Objective: To translate proteomic and metabolomic signatures from cerebrospinal fluid (CSF) into plasma biomarkers